3-(tert-Butoxycarbonyl)-3-azabicyclo[3.2.1]octane-8-carboxylic acid, 95.0%, 5g

2-Chloro-4-fluorochalcone, 5g

1-(1-Methyl-1H-indazol-4-yl)ethanone, 95.0%, 250mg

L(+)-tartaric acid, min. 99.5%, pa, ACS, ISO, 1 kg, plastic packaging.

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 10mg

2-METHYL-4-TRIFLUOROMETHOXYANILINE, 95.0%, 10g

(S)-4-((S)-sec-Butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole, 97%, 100mg

N-Methoxy-n-methylpropionamide, 95.0%, 100g

5-(2-Nitrophenyl)-1,3,4-thiadiazol-2-amine, 250mg

1,2,3,4-Cyclopentanetetracarboxylic Dianhydride (purified by sublimation)>99.0%(T)5g

N-Ethyl-N-methyl-2-(piperazin-1-yl)nicotinamide, 95%, 250mg

3-(Difluoromethoxy)-4-fluorobenzaldehyde, 95.0%, 250mg

2-Ethynyl-4-methoxypyridine, 500mg